Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PF 06936308

Drug Profile

PF 06936308

Alternative Names: PF-06936308; Vaccine-based immunotherapy regimen-2; VBIR-2

Latest Information Update: 18 Nov 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pfizer
  • Class Antineoplastics; Cancer vaccines; Immunotherapies
  • Mechanism of Action Immunologic cytotoxicity
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Non-small cell lung cancer; Triple negative breast cancer

Most Recent Events

  • 27 Sep 2021 Pfizer terminates a phase I trial in Non-small cell lung cancer and Breast cancer in USA (NCT03674827)
  • 28 Jul 2021 Discontinued - Phase-I for Non-small cell lung cancer (Late-stage disease) in USA (Parenteral) (Pfizer pipeline, July 2021)
  • 28 Jul 2021 Discontinued - Phase-I for Triple negative Breast cancer (Late-stage disease) in USA (Parenteral) (Pfizer pipeline, July 2021)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top